MHRA consults on supply chain anticounterfeiting measures again
This article was originally published in SRA
The UK Medicines and Healthcare products Regulatory Agency is seeking feedback on updated proposals to strengthen the drug supply chain in a bid to cut the number of counterfeit medicines1.
You may also be interested in...
Industry access to real world data for regulatory and market access purposes in Asia Pacific compares poorly with the US.
Draft guidelines due out for consultation this week in Italy are expected to shed more light on what companies will have to reveal during pricing and reimbursement negotiations.
Germany is for the first time to adopt national guidelines on prescribing biologics and biosimilars in a move towards increasing biosimilar uptake.